343 related articles for article (PubMed ID: 25501928)
21. Reducing effect of mangiferin on serum uric acid levels in mice.
Niu Y; Lu W; Gao L; Lin H; Liu X; Li L
Pharm Biol; 2012 Sep; 50(9):1177-82. PubMed ID: 22881143
[TBL] [Abstract][Full Text] [Related]
22. Discovery of novel 1,2,4-triazole derivatives as xanthine oxidoreductase inhibitors with hypouricemic effects.
Yang Y; Yan D; Cheng H; Nan G; Hou X; Ren L; Yang Y; Li X; Tian J; Ye F; Xiao Z
Bioorg Chem; 2022 Dec; 129():106162. PubMed ID: 36183564
[TBL] [Abstract][Full Text] [Related]
23. Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.
Ernst ME; Fravel MA
Clin Ther; 2009 Nov; 31(11):2503-18. PubMed ID: 20109996
[TBL] [Abstract][Full Text] [Related]
24. Cell biology of molybdenum.
Mendel RR
Biofactors; 2009; 35(5):429-34. PubMed ID: 19623604
[TBL] [Abstract][Full Text] [Related]
25. Role of XDHC in Molybdenum cofactor insertion into xanthine dehydrogenase of Rhodobacter capsulatus.
Leimkühler S; Klipp W
J Bacteriol; 1999 May; 181(9):2745-51. PubMed ID: 10217763
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and pharmacodynamics of febuxostat (TMX-67), a non-purine selective inhibitor of xanthine oxidase/xanthine dehydrogenase (NPSIXO) in patients with gout and/or hyperuricemia.
Komoriya K; Hoshide S; Takeda K; Kobayashi H; Kubo J; Tsuchimoto M; Nakachi T; Yamanaka H; Kamatani N
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1119-22. PubMed ID: 15571213
[TBL] [Abstract][Full Text] [Related]
27. The molybdenum cofactor biosynthesis protein MobA from Rhodobacter capsulatus is required for the activity of molybdenum enzymes containing MGD, but not for xanthine dehydrogenase harboring the MPT cofactor.
Leimkühler S; Klipp W
FEMS Microbiol Lett; 1999 May; 174(2):239-46. PubMed ID: 10339814
[TBL] [Abstract][Full Text] [Related]
28. Role and oxidation state of the pterin molybdenum cofactor of molybdenum enzymes: studies of a Drosophila melanogaster xanthine dehydrogenase (rosy) variant, G1011E.
Doyle WA; Chovnick A; Whittle JR; Bray RC
Biochem Soc Trans; 1996 Feb; 24(1):14S. PubMed ID: 8674630
[No Abstract] [Full Text] [Related]
29. Mechanism of inhibition of xanthine oxidoreductase by allopurinol: crystal structure of reduced bovine milk xanthine oxidoreductase bound with oxipurinol.
Okamoto K; Eger BT; Nishino T; Pai EF; Nishino T
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):888-93. PubMed ID: 18600558
[TBL] [Abstract][Full Text] [Related]
30. The functional principle of eukaryotic molybdenum insertases.
Krausze J; Hercher TW; Zwerschke D; Kirk ML; Blankenfeldt W; Mendel RR; Kruse T
Biochem J; 2018 May; 475(10):1739-1753. PubMed ID: 29717023
[TBL] [Abstract][Full Text] [Related]
31. The molybdenum cofactor enzyme mARC: Moonlighting or promiscuous enzyme?
Llamas A; Chamizo-Ampudia A; Tejada-Jimenez M; Galvan A; Fernandez E
Biofactors; 2017 Jul; 43(4):486-494. PubMed ID: 28497908
[TBL] [Abstract][Full Text] [Related]
32. Molybdenum-cofactor-containing enzymes: structure and mechanism.
Kisker C; Schindelin H; Rees DC
Annu Rev Biochem; 1997; 66():233-67. PubMed ID: 9242907
[TBL] [Abstract][Full Text] [Related]
33. The molybdenum cofactor.
Mendel RR
J Biol Chem; 2013 May; 288(19):13165-72. PubMed ID: 23539623
[TBL] [Abstract][Full Text] [Related]
34. Beyond Moco Biosynthesis-Moonlighting Roles of MoaE and MOCS2.
Suganuma T
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744859
[TBL] [Abstract][Full Text] [Related]
35. Chemistry and biology of the molybdenum cofactors.
Rajagopalan KV; Johnson JL; Wuebbens MM; Pitterle DM; Hilton JC; Zurick TR; Garrett RM
Adv Exp Med Biol; 1993; 338():355-62. PubMed ID: 8304138
[No Abstract] [Full Text] [Related]
36. Molecular characterization of human xanthine oxidoreductase: the enzyme is grossly deficient in molybdenum and substantially deficient in iron-sulphur centres.
Godber BL; Schwarz G; Mendel RR; Lowe DJ; Bray RC; Eisenthal R; Harrison R
Biochem J; 2005 Jun; 388(Pt 2):501-8. PubMed ID: 15679468
[TBL] [Abstract][Full Text] [Related]
37. Identification of persulfide-binding and disulfide-forming cysteine residues in the NifS-like domain of the molybdenum cofactor sulfurase ABA3 by cysteine-scanning mutagenesis.
Lehrke M; Rump S; Heidenreich T; Wissing J; Mendel RR; Bittner F
Biochem J; 2012 Feb; 441(3):823-32. PubMed ID: 22004669
[TBL] [Abstract][Full Text] [Related]
38. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity.
Furuhashi M
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E827-E834. PubMed ID: 32893671
[TBL] [Abstract][Full Text] [Related]
39. Identification of a cyclic nucleotide as a cryptic intermediate in molybdenum cofactor biosynthesis.
Hover BM; Loksztejn A; Ribeiro AA; Yokoyama K
J Am Chem Soc; 2013 May; 135(18):7019-32. PubMed ID: 23627491
[TBL] [Abstract][Full Text] [Related]
40. Structure of a putative molybdenum-cofactor biosynthesis protein C (MoaC) from Sulfolobus tokodaii (ST0472).
Yoshida H; Yamada M; Kuramitsu S; Kamitori S
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Jul; 64(Pt 7):589-92. PubMed ID: 18607082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
